What Researchers Did
Researchers treated 48 patients with diabetic foot ulcers using hyperbaric oxygen therapy (HBOT) to investigate changes in insulin-like growth factor I (IGF-1) levels and their predictive value for wound healing.
What They Found
Initial IGF-1 levels were not significantly different between groups (P = 0.399), but the mean IGF-1 level increased overall with HBOT (P < 0.05). In patients whose wounds healed, the mean IGF-1 increase and final values were significantly higher (P < 0.05), with the increase in IGF-1 being significantly greater in the healed group (P < 0.001).
What This Means for Canadian Patients
Hyperbaric oxygen therapy could be a valuable treatment option for Canadian patients suffering from diabetic foot ulcers, potentially improving healing outcomes. Monitoring IGF-1 levels might help identify which patients are responding well to HBOT, guiding treatment decisions.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
A potential limitation of this study is its relatively small sample size of 48 patients, which may limit the generalizability of the findings.